Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
Canada
Politics
World
En français
Sports
Business
Lifestyle
AI
Tech
Science

"Ionis"
Topics

Advertisement

Advertisement

"Ionis"

Showing articles that match "Ionis" in the headline

In the last 6 hours

Investors Dumped Ionis Pharmaceuticals Stock -- But Wall Street Hasn't Budged From Its Bullish Outlook The Motley Fool 14:44

Yesterday

Pelacarsen Trial Failure Might Change The Case For Investing In Ionis Stock (IONS) Simply Wall St 06:56 Sat, 19 Sep

In the last month

Cathie Wood Is Loading Up on Ionis Pharmaceuticals (IONS) Stock. Here's the Bet She's Making. The Motley Fool 21:41 Wed, 09 Sep

Advertisement

Advertisement

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session Benzinga 13:01 Tue, 08 Sep

Novartis, Ionis drug failure spurs questions about an emerging class of heart medicines BioPharma Dive 01:38 Sun, 06 Sep

Ionis partner Novartis announces Lp(a)horizon Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD) Business Wire (Press Release) 21:42 Fri, 04 Sep

World to conquer: Alexander FDA nod turns Ionis to diagnostics BioWorld 21:04 Fri, 04 Sep

Ionis chalks up CNS win as FDA greenlights Zanvastro in Alexander disease BioWorld 16:40 Fri, 04 Sep

Ionis nets Zanvastro US approval in first for Alexander disease Pharmaceutical Technology 11:45 Fri, 04 Sep

Ionis claims first approval for Alexander disease therapy pharmaphorum 09:43 Fri, 04 Sep

Ionis’ Zanvastro Is First Disease-Modifying Drug For Alexander Disease Scrip Pharma Intelligence 22:46 Thu, 03 Sep

STAT Plus: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder STAT 21:48 Thu, 03 Sep

Ionis to present at upcoming investor conferences Business Wire (Press Release) 12:05 Thu, 03 Sep

Here's Why Ionis Pharmaceuticals' Steep Sell-off Was Overdone The Motley Fool 10:08 Thu, 03 Sep

ESC26: Can Arrowhead pierce Ionis' triglyceride armour? pharmaphorum 19:23 Mon, 31 Aug

ESC: Wainua Data From AstraZeneca/Ionis Undercut ATTR-CM Combo Case Scrip Pharma Intelligence 10:14 Mon, 31 Aug

STAT Plus: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching STAT 14:41 Fri, 28 Aug

Advertisement

Breakfast News: A Conversation With Ionis CEO The Motley Fool 12:54 Sat, 22 Aug

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
Canada Canada
Politics Politics
World World
En français
Sports Sports
Business Business
Lifestyle Lifestyle
AI AI
Tech Tech
Science Science